| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/22/1993 | WO1993014072A1 Amino acid derivatives as paf-receptor antagonists |
| 07/22/1993 | WO1993014070A2 Novel imidazole derivatives, their preparation and therapeutic applications |
| 07/22/1993 | WO1993014069A1 Heterocyclic sulfonamide derivatives as antagonists of paf and angiotensin ii |
| 07/22/1993 | WO1993014068A1 Novel salts of a quinolone-carboxylic acid |
| 07/22/1993 | WO1993014067A1 Nitroquinolone derivatives as nmda antagonists |
| 07/22/1993 | WO1993013806A1 Inactivation of cytotoxic drugs |
| 07/22/1993 | WO1993013805A1 Cytotoxic drug therapy |
| 07/22/1993 | WO1993013804A1 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
| 07/22/1993 | WO1993013801A1 Treatment for atherosclerosis |
| 07/22/1993 | WO1993013795A1 Medical use, a medical method and a pharmaceutical preparation |
| 07/22/1993 | WO1993013793A1 Pharmaceutical bacteriocin compositions |
| 07/22/1993 | WO1993013783A1 An iron-containing composition for the prevention of anaemia and a method for producing the composition |
| 07/22/1993 | WO1993013782A1 Use of ruthenium red for inhibiting immune response |
| 07/22/1993 | WO1993013781A1 Cholesterol level depressant |
| 07/22/1993 | WO1993013780A1 4''-deoxyerythromycin derivatives |
| 07/22/1993 | WO1993013779A2 Use of udpg as cancer therapy rescue agent |
| 07/22/1993 | WO1993013778A1 Therapeutic nucleosides |
| 07/22/1993 | WO1993013777A1 Method of using m1-selective antimuscarinic pyridobenzodiazepinones in axial myopia therapy |
| 07/22/1993 | WO1993013776A1 Use of paf antagonists in the treatment of dysmenorrhea |
| 07/22/1993 | WO1993013775A1 Diaminopyridine compounds for the inhibition of protein glycosylation |
| 07/22/1993 | WO1993013774A1 Methods for preventing mycobacterial infections with rifabutin |
| 07/22/1993 | WO1993013773A1 Pharmaceutical compositions containing nifedipine and process for the preparation thereof |
| 07/22/1993 | WO1993013772A1 Methods for using histamine derivatives as immunomodulators and in immunotherapeutics |
| 07/22/1993 | WO1993013771A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 07/22/1993 | WO1993013770A1 Drug for use in ophthalmological and/or in otorhinolaryngological therapy and process for the production thereof |
| 07/22/1993 | WO1993013769A1 Pyropheophorbides and their use in photodynamic therapy |
| 07/22/1993 | WO1993013766A1 Treatment of involuntary movements with 5ht1a receptor agonists |
| 07/22/1993 | WO1993013765A1 Lecithin-containing solutions with levemopamil |
| 07/22/1993 | WO1993013764A1 Pharmaceutical preparation of antistress, stress-preventive and nootropic action |
| 07/22/1993 | WO1993013763A1 Method of treating small mouth ulcers |
| 07/22/1993 | WO1993013762A1 Inhibitor for restenosis after percutaneous coronary arterioplasty |
| 07/22/1993 | WO1993013751A1 Formulation and use of carotenoids in treatment of cancer |
| 07/22/1993 | WO1993013741A2 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
| 07/22/1993 | WO1993013740A2 Antiparasitic oligonucleotides active against drug resistant malaria |
| 07/22/1993 | WO1993013660A1 Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
| 07/22/1993 | WO1993011115A3 Quinolone derivatives and their use as nmda and ampa receptor antagonists |
| 07/22/1993 | WO1993010783A3 Quinolone derivatives and their use as ampa and nmda receptor antagonists |
| 07/22/1993 | WO1993010742A3 Chemical compounds, their preparation and use |
| 07/22/1993 | WO1993009778A3 Use of brl 38227 for the treatment and prophylaxis of hyperlipidemia |
| 07/22/1993 | WO1993007262A3 Purified chitin deacetylase |
| 07/22/1993 | WO1993006852A3 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/22/1993 | DE4201527A1 Lecithinhaltige loesungen mit levemopamil Lecithin-containing loesungen with levemopamil |
| 07/22/1993 | DE4201147A1 Treatment of allergic rhinitis using pAF antagonists - e.g. thieno-, cyclopenta-(4,5)-thieno- or 2,3,4,5-tetra:hydro-8H-pyrido-(4,5)thieno-(3,2-f) (1,2,4) triazolo-(4,3-a) (1,4) diazepine |
| 07/22/1993 | CA2368862A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2351694A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2314425A1 Imidazole derivatives and their use as cytokine inhibitors |
| 07/22/1993 | CA2128429A1 Method of treating small mouth ulcers |
| 07/22/1993 | CA2128331A1 Methods for using histamine derivatives as immunomodulators and in immunotherapeutics |
| 07/22/1993 | CA2128234A1 Disubstituted polycyclic systems as cognition enhancers |
| 07/22/1993 | CA2128233A1 Novel neurotransmitter releasers useful for cognition enhancement |
| 07/22/1993 | CA2127457A1 Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone |
| 07/22/1993 | CA2127436A1 Carbamate derivatives and their use in medicine |
| 07/22/1993 | CA2127367A1 Heterocyclic sulfonamide derivatives as antagonists of paf and angiotensin ii |
| 07/22/1993 | CA2127365A1 Amino acid derivatives as paf-receptor antagonists |
| 07/22/1993 | CA2127356A1 Narrow poly-and mono-dispersed anionic oligomers, and their uses, formulations and process |
| 07/22/1993 | CA2127295A1 Peptide linkage unit comprising methylene phosphinic acid |
| 07/22/1993 | CA2127274A1 Process for preparing 3-acylestratrienes and acylbenzenes |
| 07/22/1993 | CA2127251A1 Heterocyclic compounds and their preparation and use |
| 07/22/1993 | CA2126979A1 Antiparasitic oligonucleotides active against drug resistant malaria |
| 07/22/1993 | CA2126864A1 Pharmaceutical compositions containing nifedipine and process for the preparation thereof |
| 07/22/1993 | CA2126687A1 Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents |
| 07/22/1993 | CA2126554A1 Treatment of involuntary movements with 5ht1a receptor agonists |
| 07/22/1993 | CA2126076A1 Nitroquinolone derivatives as nmda antagonists |
| 07/22/1993 | CA2125478A1 4"-deoxyerythromycin derivatives |
| 07/22/1993 | CA2125182A1 Piperazine derivatives as 5-ht receptors antagonists |
| 07/22/1993 | CA2124217A1 Inactivation of cytotoxic drugs |
| 07/22/1993 | CA2117385A1 Use of ruthenium red for inhibiting immune response |
| 07/22/1993 | CA2106457A1 Difluoromethylenandrostenone derivatives and process for their preparation |
| 07/22/1993 | CA2105466A1 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
| 07/22/1993 | CA2105284A1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 07/22/1993 | CA2087656A1 New compounds |
| 07/22/1993 | CA2087651A1 Compounds |
| 07/22/1993 | CA2087510A1 Method of using m1-selective antimuscarinic pyridobenzodiazepiones in axial myopia therapy |
| 07/21/1993 | EP0552138A2 Use of esters of acyl carnitines with long-chain aliphatic alcohols in the preparation of pharmaceutical compositions having antimycotic activity |
| 07/21/1993 | EP0552137A2 Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity |
| 07/21/1993 | EP0552060A1 Imidazole derivatives having anti-HIV activity |
| 07/21/1993 | EP0552057A1 Azauridine compounds in the treatment of rheumatoid arthritis |
| 07/21/1993 | EP0552031A1 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 07/21/1993 | EP0552018A1 Use of Rifabutin for delaying or preventing mycobacterial infections |
| 07/21/1993 | EP0551963A2 Use of heterocyclic derivatives for the manufacture of medicaments |
| 07/21/1993 | EP0551860A1 PAF-antagonists as medicaments for the treatment of dysmenorrhea |
| 07/21/1993 | EP0551849A1 Novel arylcycloalkyl derivatives their production and their use |
| 07/21/1993 | EP0551848A1 Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and polyvinylalcohol |
| 07/21/1993 | EP0551844A2 Bile acid sulfurated derivatives |
| 07/21/1993 | EP0551820A1 Taste-masked pharmaceutical compositions |
| 07/21/1993 | EP0551729A1 Gamma-linolenic acid for the preparation of a medicament for preventing reocclusion of arteries |
| 07/21/1993 | EP0551675A1 Oral hygiene compositions containing antiplaque agents |
| 07/21/1993 | EP0551663A1 Dimethyl 2,6-dimethyl-1n-propyl-4-(4-trifluormethylphenyl)-1,4-dihydro-pyridine-3,5-dicarboxylate, method for its production and its pharmaceutical use |
| 07/21/1993 | EP0551662A1 Benzofuranyl- and thiophenylmethylthio-alcanecarboxylic acid derivatives |
| 07/21/1993 | EP0551501A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 07/21/1993 | EP0551451A1 N-alkyl-tauroursodeoxycholic acids and their therapeutically active derivatives, a process for their preparation and pharmaceutical compositions containing them |
| 07/21/1993 | EP0551445A1 Method of administering amiloride |
| 07/21/1993 | EP0551442A1 Self-assembling ion pair drugs |
| 07/21/1993 | EP0551432A1 4,5,6,7-tetrahydro-1h-imidazo 4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists |
| 07/21/1993 | EP0551428A1 Acidic polycyclic ether antibiotic |
| 07/21/1993 | EP0551427A1 Beta-carotene and vitamin e therapy for inhibition of major vascular events |
| 07/21/1993 | EP0551354A1 Use of a heparinfraction |
| 07/21/1993 | EP0551321A1 Composition containing steroid derivatives |
| 07/21/1993 | EP0551312A1 Peri-condensed benzazepines |
| 07/21/1993 | EP0551291A1 Therapeutic (paf antagonists) agents |